INTEGRATED BIOPHARMA, INC.

Company

INTEGRATED BIOPHARMA INC

Filed

October 28, 2005

Period of Report

October 28, 2005

Accession Number

0001016504-05-000033

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →